Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism

Objective Patients with hypopituitarism have adverse cardiovascular morbidity and reduced bone mineral density (BMD). The objective of this study was to analyse the effects of glucocorticoid (GC) replacement on cardiovascular risk factors and BMD in patients with hypopituitarism.